# Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation

> **NCT02533180** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 100 (actual)

## Conditions studied

- Liver Transplant
- Liver Transplantation

## Interventions

- **BIOLOGICAL:** Immunosuppression withdrawal

## Key facts

- **NCT ID:** NCT02533180
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-15
- **Primary completion:** 2020-02-10
- **Final completion:** 2022-07-08
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-09-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02533180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02533180, "Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02533180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*